Gut bacteria and immune response in infants with severe RSV
Part of Infections, Lungs & breathing clinical trials.
This study looks at how the bacteria in the gut and the immune system respond in infants hospitalized with severe RSV infection. It may help doctors understand why some babies get sicker and could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be between 1 and 24 months old.
- Your baby must have tested positive for RSV (a common respiratory virus) and have symptoms like coughing or trouble breathing.
- Your baby must not have been born very early (before 32 weeks) or weighed less than 3.3 pounds at birth.
- Your baby must not have chronic health conditions like heart or lung disease, or a weak immune system.
- Your baby must not have taken antibiotics in the last 2 weeks or probiotics in the last 4 weeks.
- Your baby must not have other infections at the same time, and a stool sample must be collected within 24 hours of admission.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the germs in a baby's gut and their immune system respond to bronchiolitis (a common lung infection). If your baby is under 12 months and gets bronchiolitis during the RSV season, their participation could help us understand why some babies get very sick and others don't.
This study follows babies under 12 months old who are hospitalized with bronchiolitis to understand their treatment and outcomes. It includes tracking RSV testing and a new immunization called nirsevimab, which may help protect against severe illness.
This study tracks young children under 5 who arrive at certain hospital emergency departments in Türkiye with RSV (a virus that causes colds and breathing trouble). By watching their symptoms and care, doctors hope to learn more about how RSV affects children and improve treatment.
This study looks at how RSV (a common virus that can affect breathing) leads to illness in young children who come to the doctor with ear infections and/or breathing symptoms. It may help doctors better understand the “burden” RSV causes in both home/outpatient and hospital settings.
This study looks for markers in the blood that can tell how serious an RSV infection might become. If you are hospitalized with RSV and have breathing symptoms, this trial will follow your recovery and test for clues about your illness.
This study looks at how gut bacteria and immune markers relate to respiratory infections in children. It may help doctors understand why some children get sick more often and could lead to better treatments.
Hear when a new Bronchiolitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.